Braveheart Bio, Inc. — Form 10-Q
Filed September 8, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Travis Murdoch and CFO J. Paul Rickey issued routine Sarbanes-Oxley certifications (dated September 8, 2026) for the quarterly report ending June 30, 2026, certifying the accuracy of financial statements, adequacy of disclosure controls, and absence of material internal control weaknesses. No specific financial metrics, transactions, or material changes were disclosed in these boilerplate certification exhibits.
Why this rating
Routine SOX compliance certification; no new information, transactions, or control issues disclosed. Standard periodic SEC filing requirement.
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.